pI: 9.303 |
Length (AA): 612 |
MW (Da): 68859 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
42 | 91 | 2bay (A) | 3 | 53 | 22.00 | 0.00000031 | 0.3 | 0.47 | -1.72 |
307 | 590 | 1ihg (A) | 6 | 292 | 25.00 | 0 | 0.99 | 0.58 | 0.58 |
315 | 502 | 1zkc (A) | 276 | 452 | 48.00 | 0 | 1 | 0.73 | -0.78 |
321 | 483 | 2fu0 (A) | 8 | 158 | 37.00 | 0 | 1 | 0.74 | -0.9 |
42 | 90 | 4wz3 (B) | 37 | 85 | 35.00 | 0.08 | 0.65 | 0.597865 | -1.09 |
42 | 82 | 2ecj (A) | 18 | 58 | 20.00 | 0.042 | 0.06 | 0.219193 | 0.24 |
313 | 523 | 5ex1 (A) | 30 | 264 | 21.00 | 0 | 1 | 0.551171 | -0.22 |
317 | 488 | 3bo7 (A) | 5 | 176 | 99.99 | 0 | 1 | 1.49185 | -1.57 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Oocyst, ME49 Bradyzoite. | Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Tachyzoite, ME49 merozoite. | Gregory Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite. | Gregory |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_129895)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G67530 | peptidyl-prolyl cis-trans isomerase-like 2 |
Babesia bovis | BBOV_II006190 | Peptidyl-prolyl cis-trans isomerase 4 |
Brugia malayi | Bm1_21700 | cyclophilin-type peptidyl-prolyl cis-trans isomerase-4, Bmcyp-4 |
Caenorhabditis elegans | CELE_F59E10.2 | Protein CYN-4 |
Dictyostelium discoideum | DDB_G0284323 | Ubox domain-containing protein |
Drosophila melanogaster | Dmel_CG7747 | CG7747 gene product from transcript CG7747-RA |
Echinococcus granulosus | EgrG_000765500 | peptidyl prolyl cis trans isomerase 2 |
Echinococcus multilocularis | EmuJ_000765500 | peptidyl prolyl cis trans isomerase 2 |
Homo sapiens | ENSG00000100023 | peptidylprolyl isomerase (cyclophilin)-like 2 |
Loa Loa (eye worm) | LOAG_05139 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11100 | hypothetical protein |
Mus musculus | ENSMUSG00000022771 | peptidylprolyl isomerase (cyclophilin)-like 2 |
Neospora caninum | NCLIV_070210 | peptidyl-prolyl cis-trans isomerase, putative |
Oryza sativa | 4331972 | Os03g0201100 |
Schistosoma japonicum | Sjp_0043890 | ko:K10598 peptidyl-prolyl cis-trans isomerase-like 2, putative |
Schistosoma mansoni | Smp_021160.2 | peptidyl-prolyl cis-trans isomerase-like 2 ppil2 |
Schmidtea mediterranea | mk4.001416.05 | |
Toxoplasma gondii | TGME49_305940 | peptidyl-prolyl cis-trans isomerase, cyclophilin-type domain-containing protein |
Theileria parva | TP02_0580 | peptidyl-prolyl cis-trans isomerase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_F59E10.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
TGME49_305940 this record | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Cyclophilin A | 164 aa | 33.6% | 140 aa | Compounds | References |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase | 171 aa | 35.1% | 148 aa | Compounds | References |